ArticleJournal for immunotherapy of cancer2025

Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma.

Pengpeng Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.